Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 4/2008

Content (14 Articles)

Original Article

A novel murine model of allogeneic vaccination against prostate cancer

M.-C. Labarthe, P. Theocharous, N. Russell, S. Todryk, C. Bangma, P. Thraves, A. G. Dalgleish, M. A. Whelan

Original Article

Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes

Jan Dörrie, Niels Schaft, Ina Müller, Verena Wellner, Tanja Schunder, Jens Hänig, Gertie J. Oostingh, Michael P. Schön, Caroline Robert, Eckhart Kämpgen, Gerold Schuler

Original Article

Transient downregulation of monocyte-derived dendritic-cell differentiation, function, and survival during tumoral progression and regression in an in vivo canine model of transmissible venereal tumor

Cheng-Chi Liu, Yu-Shan Wang, Ching-Yi Lin, Tien-Fu Chuang, Kuang-Wen Liao, Kwan-Hwa Chi, Mo-Fan Chen, Hsin-Chien Chiang, Rea-Min Chu

Original Article

A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis

Susanna Lewēn, He Zhou, Huai-dong Hu, Tingmei Cheng, Dorothy Markowitz, Ralph A. Reisfeld, Rong Xiang, Yunping Luo

Original Article

Vγ9Vδ2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas

Francoise Bouet-Toussaint, Florian Cabillic, Olivier Toutirais, Matthieu Le Gallo, Cécile Thomas de la Pintière, Pascale Daniel, Noëlle Genetet, Bernard Meunier, Eric Dupont-Bierre, Karim Boudjema, Véronique Catros

Original Article

CXCR5 may be involved in the attraction of human metastatic neuroblastoma cells to the bone marrow

Irma Airoldi, Claudia Cocco, Fabio Morandi, Ignazia Prigione, Vito Pistoia

Original Article

CpG-ODN but not other TLR-ligands restore the antitumor responses in old mice: the implications for vaccinations in the aged

Sanjay Sharma, Ana Lucia Dominguez, Dominique B. Hoelzinger, Joseph Lustgarten

Original Article

Priming of naive CD8+ T cells in the presence of IL-12 selectively enhances the survival of CD8+CD62Lhi cells and results in superior anti-tumor activity in a tolerogenic murine model

C. Marcela Díaz-Montero, Sabry El Naggar, Amir Al Khami, Randa El Naggar, Alberto J. Montero, David J. Cole, Mohamed L. Salem

Original Article

The fibronectin attachment protein of bacillus Calmette-Guerin (BCG) mediates antitumor activity

Haley W. Sinn, Bennett D. Elzey, Robert J. Jensen, Xiuqin Zhao, Weicheng Zhao, Timothy L. Ratliff

Original Article

Saccharomyces cerevisiae, the Baker’s Yeast, suppresses the growth of Ehrlich carcinoma-bearing mice

Mamdooh Ghoneum, Nariman K. Badr El-Din, Eman Noaman, Lucilene Tolentino

Meeting Report

Progress in vaccination against cancer-7: report of the meeting in Stockholm, September 10–11, 2007

R. Kiessling, A. De Geer, C. Johansson, I. Poschke, C. Triulzi, S. Vertuani

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine